AMCR
Amcor plc
AMCR has the edge over BABA overall, supported by stronger fundamentals and stronger valuation.
BABA
Alibaba Group Holding Limited
BABA offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
AMCR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
AMCR's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
AMCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $38.71 | -12% |
| Current | 19x | $43.80 | — |
| Fair | 21x | $49.43 | +13% |
| Expensive | 28x | $64.25 | +47% |
Historical ranges are pointers, not guarantees.
AMCR has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
AMCR Forward outlook
There aren't enough analyst estimates for AMCR to show an outlook.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
AMCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.33 | +36% |
| Q2 2026 | $2.38 | +31% |
| Q1 2026 | $1.45 | -48% |
| Q4 2025 | $1.53 | -45% |
| Q3 2025 | $1.71 | -36% |
| Q2 2025 | $1.81 | -28% |
| Q1 2025 | $2.80 | +24% |
| Q4 2024 | $2.76 | +25% |
AMCR's earnings per share have fallen from their peak: $2.33 over the past year, against $3.56 in late 2022.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over AMCR on earnings, with stronger typical year-over-year growth.
AMCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.1B | +6.7% |
| Q2 2026 | $6.4B | +26% |
| Q1 2026 | $5.9B | +77% |
| Q4 2025 | $5.4B | +68% |
| Q3 2025 | $5.7B | +71% |
| Q2 2025 | $5.1B | +44% |
| Q1 2025 | $3.3B | -2.3% |
| Q4 2024 | $3.2B | -0.3% |
AMCR's revenue has grown year over year for six quarters in a row: $6.1B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.6 points |
| Q2 2026 | 10% | +8.4 points |
| Q1 2026 | 7.8% | -1.6 points |
| Q4 2025 | 6.1% | -3.1 points |
| Q3 2025 | 8% | -1.3 points |
| Q2 2025 | 1.7% | -9.5 points |
| Q1 2025 | 9.4% | +0.4 points |
| Q4 2024 | 9.2% | +1.7 points |
AMCR has the edge over BABA on profitability, with a higher operating margin.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
AMCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$828M | -$457M |
| Q2 2026 | $1.4B | +52% |
| Q1 2026 | -$42M | -$42M |
| Q4 2025 | $282M | -15% |
| Q3 2025 | -$371M | +$43M |
| Q2 2025 | $894M | +11% |
| Q1 2025 | $0 | -100% |
| Q4 2024 | $330M | +36% |
AMCR has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
AMCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +800K shares |
| 1 year | +0.3% | +1.6M shares |
| 3 years | +57% | +169M shares |
| 5 years | +49% | +153M shares |
| Available history | +44% | +142M shares |
AMCR has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
AMCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 5.2x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 6.7x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.5x | Elevated |
AMCR's net debt is about 4.2 years of its operating earnings (EBITDA), down from 6.7 years a year ago.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over AMCR on leverage, with a lower net debt burden relative to earnings.
AMCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 53.5 | Neutral |
AMCR's weekly RSI is 50 (neutral) and its Stochastic is 54 (neutral).
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
AMCR PE vs Consumer Cyclical Sector
| Metric | AMCR | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 4.1% above |
| PE % | 27 | 47 | 20 pts below |
AMCR has the edge over BABA on valuation relative to its sector.
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
AMCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.0 | 0.5% below |
| 20 week MA | $44.6 | 1.8% below |
| 50 week MA | $42.9 | 2% above |
| 100 week MA | $44.3 | 1.2% below |
| 200 week MA | $47.4 | 7.5% below |
AMCR has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
AMCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.8 | $58.2 | +6.3% |
| 2021 | $58.2 | $58.3 | +0.2% |
| 2022 | $58.3 | $60.3 | +3.4% |
| 2023 | $60.3 | $48.2 | -20% |
| 2024 | $48.2 | $47.2 | -2.1% |
| 2025 | $47.2 | $41.6 | -12% |
| 2026 YTD | $41.6 | $43.8 | +5.3% |
AMCR has the edge over BABA on returns for 2026, with the stronger performance.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.